ON GELSEMINUM SEMPERVIRENS. (Continued from. p. 417.)
نویسندگان
چکیده
منابع مشابه
P -adic Continued Fractions
Continued fractions in R have a single definition and algorithms for approximating them are well known. There also exists a well known result which states that √ m, m ∈ Q, always has a periodic continued fraction representation. In Qp, the field of p-adics, however, there are competing and non-equivalent definitions of continued fractions and no single algorithm exists which always produces a p...
متن کاملNew triterpenoidal alkaloids from Buxus sempervirens.
Phytochemical studies on the ethanolic extract of the roots of Buxus sempervirens of Turkish origin have resulted in the isolation of two new triterpenoidal alkaloids, (+)-16a, 31-diacetylbuxadine (1), (-)-Nb-demethylcyclomikuranine (2) along with three known natural products, (-)-cyclomikuranine (3), (-)-cyclobuxophylline-K (4) and (+)-buxaquamarine (5) isolated for the first time from this sp...
متن کاملSuperior Mesenteric Artery Syndrome 417
Superior mesenteric artery syndrome (SMAS) mostly occurs in adolescent or young adults and is a rare disorder. The syndrome was first described by the Von Rokitansky in 1842 and since then about 400 cases has been reported in literature but SMAS is not well recognised and often diagnosed late till the patients are far advanced with their symptoms (Geer 1990, Raissi et al1996). In general popula...
متن کاملNpgRJ_Nchembio_801 417..422
G protein–coupled receptors (GPCRs) regulate a wide variety of physiological functions in response to structurally diverse ligands ranging from cations and small organic molecules to peptides and glycoproteins. For many GPCRs, structurally related ligands can have diverse efficacy profiles. To investigate the process of ligand binding and activation, we used fluorescence spectroscopy to study t...
متن کاملDmd061820 411..417
Brain metastasis (BM) is increasingly diagnosed in Her2 positive breast cancer (BC) patients. Lack of effective treatment to breast cancer brain metastases (BCBMs) is probably due to inability of the current therapeutic agents to cross the blood-brain barrier. The central nervous system (CNS) response rate in BCBM patients was reported to improve from 2.6%–6% (lapatinib) to 20%–65% (lapatinib i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1876
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)21256-8